Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Rgenta Therapeutics
LabCentral
700 Main St.
Cambridge, MA 02139
Phone: 781-608-3996
https://www.rgentatx.com/

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases.

Key Contact
Name
Dr. Simon Xi
Title
CEO
Funding Events

Date
Amount
Type
Investors
04/04/20 $20,000,000 Seed Boehringer Ingelheim Venture Fund
Kaitai Capital
Legend Star
Matrix Partners